Blog
The Promise of Psychedelics | Dr. Keith Heinzerling & Louie Schwartzberg
by Anthony Effinger
Addiction and depression are two of the most widespread conditions in all of medicine. After decades of research, doctors are still looking for alternatives for when medication and cognitive training don’t work, which is all too often.
Multiple Sclerosis – A New Treatment, A New Hope
by Guest Author
A new self-administered drug for the treatment of Multiple Sclerosis has been approved by the US Food and Drug Administration (FDA). In a clinical trial, it outperformed an existing oral drug, with respect to decreasing relapses and new areas of nerve damage seen on MRI....
Optimizing Brain Health During COVID
by William Buxton
As physicians, we understand the tremendous value of cognitive, physical, and social activity in optimizing and preserving our abilities as we age. At first glance, it is easy to see COVID as an obstacle. However, there are many ways we can emerge from this period sharper, stronger and more resilient.
Clinical Trials Round-Up: November 2020
by Mini Gill
Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...
New Drug for Lewy Body Dementia Shows Promise
by Guest Author
Drug shows encouraging signs for patients of less common type of dementia. Pacific Neuroscience Institute located at Providence Saint John’s Health Center among sites for clinical trial.
Treating the “Suicide Disease” with a Light Touch | Dr. Garni Barkhoudarian
by Anthony Effinger
Ever heard of a disease called Trigeminal Neuralgia? It’s called the “Suicide Disease” because it causes unbearable pain in the face and temples. It’s often triggered by everyday things like brushing teeth, shaving, or putting on makeup.
ZBT Fraternity at UCLA Donates to PNI’s Brain Cancer Program
by Guest Author
Jack Verschleiser, a 2017 UCLA graduate who now oversees the university’s ZBT fraternity organization, was struck that two current members had personal experience with cancer. David Phillips, who graduated in June of this year successfully battled Hodgkin’s lymphoma for six months of his junior year....
Clinical Trials Round-Up: October 2020
by Mini Gill
Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...
Patient Story: Happy Days Because of a Hydrocephalus Hero
by Sharmyn McGraw
Abbie, a Beverly Hills, California resident was experiencing alarming deteriorating health with no diagnosis. Then she found neurosurgeon, Dr. Garni Barkhoudarian at Pacific Neuroscience Institute.
Embracing Aging: Helping Our Loved Ones, Helping Ourselves | Dr. Scott Kaiser
by Anthony Effinger
There just might be magic bullets to aging well. Dr. Scott Kaiser talks about his 7 pillars of success for as we get older. Find out more
Last updated: November 24th, 2020